Henry Schein celebrates 21st annual Holiday Cheer for Children program with families around the world
Henry Schein, Inc.(Melville, NY) and its employees around the world joined more than 1,200 underserved children, families, and seniors to celebrate the company’s 21st annual Holiday Cheer for Children program in December 2019, a flagship corporate initiative that helps participating families enjoy a fun and festive holiday season.
“The Holiday Cheer for Children program exemplifies our Company’s mission to support the communities in which we live and work, and the joy of celebrating with new friends and families each year only serves to reinforce our commitment to giving back,” said Gerry Benjamin, Henry Schein’s executive vice president and chief administrative officer. “It is especially rewarding to see the friendships that have formed between our TSMs, our social service agency partners, and the families we serve, and we look forward to making many more new friends in the years to come.”
Holiday Cheer for Children takes different forms depending on the location, with employees often collecting and donating gifts and food to local nonprofit organizations, or purchasing gifts for participating children and delivering them at company events. Henry Schein partners with local social service agencies to identify children and families who would most benefit from participating in the program.
Owens & Minor names David Myers as SVP and chief procurement officer
Owens & Minor, Inc.(Richmond, VA) has hiredDavid Myersas SVP and chief procurement officer. In this role, Myers will be responsible for leading global procurement, supplier relations, supplier effectiveness, category management, and the company’s GPO team. Prior to joining Owens & Minor, Myers spent 20 years at Seneca Medical, which later became Concordance Healthcare Solutions (Tiffin, OH), where was president and COO. Myers is a current board member and past board chair with the Health Industry Distributors Association (HIDA). Myers will succeedMark Zacuras EVP and CPO. Zacur was recently promoted to EVP and chief commercial officer
MTMC announces new partnership
MTMC is pleased to announce a new partnership: MTMC-IS (MTMC Inside Sales). The new company will be in partnership with and led by Joanne Wills. Joanne is the founder of Calling Works, a leader in B2B outsourced inside sales solutions (www.callingworks.com) MTMC-IS will be providing inside sales solutions to the existing portfolio of MTMC supplier partners as well as other medical suppliers that value the service.
Midmark names Nancy Stapp as VP, finance
Midmark Corp. (Dayton, OH) announced that Nancy Stapp was promoted to VP, finance. Stapp will lead the Midmark board of directors’ audit committee and be the primary interface for key discussions. She will also be responsible for driving Enterprise Risk Management (ERM) for Midmark. This includes leading the ERM internal cross-functional team, overseeing insurance evaluation and purchasing efforts, coordinating third party risk evaluations and managing the risk mitigation efforts for the company. Additionally, she will lead the communications of these activities with the Midmark Board of Directors.
CVS Health launches “Transform Oncology Care” program
CVS Health(Woonsocket, RI) announced its “Transform Oncology Care” program. The company says the program is “anchored on a first-of-its-kind precision medicine strategy for payors.” It will use genomic testing results at the point-of-prescribing to help patients start on the best treatment, faster and will match eligible patients to clinical trials. The precision medicine strategy, delivered in close coordination with oncologists, uses results of broad-panel gene sequencing tests and the latest National Comprehensive Cancer Network (NCCN) treatment and supportive care guidelines to help oncologists identify and start their patients on the most precise, appropriate treatment regimen based on their clinical and genetic profiles. Therapeutic regimens that align to NCCN guidelines, including those matched with the results of the broad-panel gene sequencing tests, will automatically receive prior authorization approval, speeding time to start of the therapy for patients. The strategy is enabled by an innovative collaboration with Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.
Products to Watch
Masimo receives FDA clearance for neonatal RD SET Pulse Oximetry Sensors
Masimo (Irvine, CA) announced that RD SET sensors with Masimo Measure-through Motion and Low Perfusion SET pulse oximetry have received FDA clearance for improved oxygen saturation (SpO2) accuracy specifications for neonatal patients (< 3 kg). The company says that the updated RD SET sensors’ SpO2 accuracy specifications have improved significantly, from 3% to 1.5% ARMS (at 1 standard deviation), in conditions of motion and no motion, providing clinicians with even greater confidence when monitoring the oxygenation status of neonates. With this clearance, the improved performance specifications, which were incorporated into RD SET sensors for patients > 3 kg in 2018, are now available to all patient populations in the U.S.
Sysmex launches gene-testing kit for blood cancer (ipsogen JAK2 DX reagent)
Sysmex Corporation announced the launch of the ipsogen JAK2 DX reagent. The product is a gene testing kit that measures the JAK2V617F mutation quantitatively, used in the diagnosis of certain hematopoietic tumors generally referred to as blood cancers, specifically polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), the company said.